5news.Canadian news, all in one place

BREAKING

› Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection › Small Business Owners Putting up Personal Assets to Keep Businesses Afloat, New Equifax Canada Survey Finds › Fortuna to release third quarter 2026 financial results on November 4, 2026; Conference call at 12 p.m. Eastern time on November 5, 2026 › Forge FC tops CF Montreal on penalty kicks to win Canadian championship › This $152-million deal raises questions about Ottawa's affordable housing strategy | Opinion › Law Society complaint questions U of Toronto law professor’s Indigenous ancestry › Atlanta Dream beat Golden State Valkyries in Game 3, take 2-1 lead in WNBA Finals › Transaction in Own Shares › Sound Point Capital Expands European Private Credit Platform With Secured Lending Team › We have a glitzy power plant — but no house for PM | Letters to the Editor › Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection › Small Business Owners Putting up Personal Assets to Keep Businesses Afloat, New Equifax Canada Survey Finds › Fortuna to release third quarter 2026 financial results on November 4, 2026; Conference call at 12 p.m. Eastern time on November 5, 2026 › Forge FC tops CF Montreal on penalty kicks to win Canadian championship › This $152-million deal raises questions about Ottawa's affordable housing strategy | Opinion › Law Society complaint questions U of Toronto law professor’s Indigenous ancestry › Atlanta Dream beat Golden State Valkyries in Game 3, take 2-1 lead in WNBA Finals › Transaction in Own Shares › Sound Point Capital Expands European Private Credit Platform With Secured Lending Team › We have a glitzy power plant — but no house for PM | Letters to the Editor

Business

Rakovina Therapeutics and Variational AI Advance Brain-Penetrant ATR Program Toward Development Candidate Selection

Financial Post · October 22, 2026 at 5:34 a.m.

kt-5000AI delivers potent and selective ATR inhibition, CNS-oriented properties and preclinical tumour-growth control, advancing a capital-efficient drug discovery program toward candidate selection VANCOUVER, British Co

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

More from Financial Post

Small Business Owners Putting up Personal Assets to Keep Businesses Afloat, New Equifax Canada Survey Finds

Financial Post · 12 min ago

Fortuna to release third quarter 2026 financial results on November 4, 2026; Conference call at 12 p.m. Eastern time on November 5, 2026

Financial Post · 43 min ago

Transaction in Own Shares

Financial Post · 1 h ago

Sound Point Capital Expands European Private Credit Platform With Secured Lending Team

Financial Post · 1 h ago

More in Business

Small Business Owners Putting up Personal Assets to Keep Businesses Afloat, New Equifax Canada Survey Finds

Financial Post · 12 min ago

Fortuna to release third quarter 2026 financial results on November 4, 2026; Conference call at 12 p.m. Eastern time on November 5, 2026

Financial Post · 43 min ago

Transaction in Own Shares

Financial Post · 1 h ago

Sound Point Capital Expands European Private Credit Platform With Secured Lending Team

Financial Post · 1 h ago

E3 Lithium Approaches Completion of Phase 2 of its Demonstration Facility and Outlines Path to Commercialization

Financial Post · 2 h ago

Ferrer and Prilenia Announce Authorization for EU Initiation of Confirmatory PRECISE-HD Study of Pridopidine in Huntington’s Disease

Financial Post · 2 h ago